Cholesterol-lowering therapy for smokers and non-smokers: a life-table analysis
- 1 December 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 356 (9246) , 2004-2006
- https://doi.org/10.1016/s0140-6736(00)03319-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Mortality in women and men in relation to smokingInternational Journal of Epidemiology, 1998
- Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield tableThe Lancet, 1996
- Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority populationBMJ, 1996
- Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor managementJournal of the American College of Cardiology, 1996
- Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart diseaseThe Lancet, 1995
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Prevention of coronary heart disease in clinical practiceEuropean Heart Journal, 1994
- Mortality from tobacco in developed countries: indirect estimation from national vital statisticsThe Lancet, 1992
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991